| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/30/2002 | CN1333246A Novel polypeptide--human large protein 53.24 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333245A Novel polypeptide--human nucleoporin p54-16.61 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333243A Novel polypeptide--human DNA CGG repetitive conjugated protein 31.57 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333241A Novel polypeptide--human signalling related protein 20.24 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333240A Novel polypeptide--human gene pleiotropic regulator 1 (PLRG1) protein 10.01 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333238A Novel polypeptide--human muscle development related protein (LRRFIP1) 10.89 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333236A Novel polypeptide--human large protein 47 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333235A Novel polypeptide-oncoprotein 11.66 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333234A Novel polypeptide--gene product 8.69 conjugated with CpG island of VIII factor gene and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333232A Novel polypeptide--dead effector structure domain DNA conjugated protein 10.89 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333231A Novel polypeptide--tight junction protein Z0-1-10.01 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333229A Novel polypeptide--TEGT protein 42.13 and polynucleotide for encoding this polypeptide |
| 01/30/2002 | CN1333228A Novel polypeptide--eukaryotic releasing factor 110.67 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333227A Novel polypeptide-cell surface protein TAPA-123.32 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333226A Novel polypeptide--butyrophilin 52.91 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333225A Novel polypeptide--oligodendrocyte-myelin glucoprotein 9.68 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333224A Novel polypeptide--LLRep3 ribosomal protein 11.88 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333223A Novel polypeptide--chromatin agregation protein 70 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333222A Novel polypeptide--degeorge syndrome key area 2-16.06 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333221A Novel polypeptide--human ubiquitin protein stable protein 9.02 and polynucleotide for coding said polypeptide |
| 01/30/2002 | CN1333220A Novel polypeptide--chromosome translocation related hot spot conjugated protein 9.79 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333218A Novel polypeptide--zinc finger protein 12.76 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333217A Novel polypeptide--pedalcalix protein similar pretein 9.46 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333216A Novel polypeptide--ring finger protein 151 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333215A Novel polypeptide--developmental regulation related protein 10.45 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333214A Novel polypeptide-four times membrane-spanning protein 14,19 and polynucleotide for encoding said polypeptide |
| 01/29/2002 | US6342595 Gene expression of jun n-terminal kinase proteins; antiproliferative agents |
| 01/29/2002 | US6342588 Conjugating biotin-tyramine label to proteins, peptides, or ligands comprising specific binding pair by use of hydrogen peroxidase enzyme; gene expression from modified nucleic acid; genetic engineering |
| 01/29/2002 | US6342587 A33 antigen specific immunoglobulin products and uses thereof |
| 01/29/2002 | US6342584 Antiproliferative, anticarcinogenic, antitumor, antiinflammatory, and antimetastasis agents; diabetes, restenosis, rheumatoid arthritis treatment; genetic engineering |
| 01/29/2002 | US6342583 Polypeptide genetically expressed by cell that is transfected, infected, or injected with cloning vehicle; genetic engineering; colorectal cancer tumor markers |
| 01/29/2002 | US6342389 Modified phycobilisomes and uses therefore |
| 01/29/2002 | US6342373 Acetyl derivatives of amino acid sequences, cultures of escherichia or saccharomyces and expression vectors |
| 01/29/2002 | US6342363 Death domain containing receptor 4 nucleic acids and methods |
| 01/29/2002 | US6342361 Method of assaying collagen fragments in body fluids, a test kit and means for carrying out the same |
| 01/29/2002 | US6342360 Dopamine receptors and genes |
| 01/29/2002 | US6342357 An isolated mutant dna; for diagnosis and therapy for cardiovascular disorders characterized by prolonation of the qt interval on electrocardiogram and the presence of syncope, seizures and sudden death |
| 01/29/2002 | US6342351 Methods and compositions for diagnosing and treating chromosome-18p related disorders |
| 01/29/2002 | US6342344 Antibody composition for isolating human cells from human-murine chimeric hematopoietic cell suspensions |
| 01/29/2002 | US6342222 Equine arteritis virus peptides, antibodies and their use in a diagnostic test |
| 01/29/2002 | US6342221 Antibody conjugate compositions for selectively inhibiting VEGF |
| 01/29/2002 | US6342220 Agonist antibodies |
| 01/29/2002 | US6342219 As anti-angiogenic and in tumor therapy |
| 01/29/2002 | US6342218 Method for treatment of SLE |
| 01/29/2002 | CA2158575C Chlamydia vaccine and process |
| 01/29/2002 | CA2155330C Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 01/29/2002 | CA2075937C Anti-human plasmin-.alpha.2- plasmin inhibitor complex antibodies, hybridomas, and immunological determination method |
| 01/24/2002 | WO2002006532A1 Novel dna polymerase iii holoenzyme delta subunit nucleic acid molecules and proteins |
| 01/24/2002 | WO2002006515A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 01/24/2002 | WO2002006492A1 A novel human soluble secreted endopeptidase (sep) for the treatment of sexual dysunfction |
| 01/24/2002 | WO2002006486A1 Fused protein with antitumor effect |
| 01/24/2002 | WO2002006482A1 Receptor protein specifically recognizing bacterial dna |
| 01/24/2002 | WO2002006466A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/24/2002 | WO2002006460A2 Masp-2, a complement-fixing enzyme, and uses for it |
| 01/24/2002 | WO2002006347A1 A selectively-expressed epitope on the human cd38 molecule detected by a phage display library-derived human scfv antibody fragment |
| 01/24/2002 | WO2002006346A1 ASSAY FOR IDENTIFYING υ2u-GLOBULIN-MEDIATED NEPHROPATHY |
| 01/24/2002 | WO2002006340A2 Tetraspan protein and uses thereof |
| 01/24/2002 | WO2002006328A2 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods |
| 01/24/2002 | WO2002006317A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 01/24/2002 | WO2002006311A2 Olfactory g-protein coupled receptor |
| 01/24/2002 | WO2002006310A1 Peptide fructose and complex thereof with binding protein |
| 01/24/2002 | WO2002006305A1 Method of collecting viral envelope from germinating baculovirus |
| 01/24/2002 | WO2002005922A1 Method for extracting proteins from plants in pure form |
| 01/24/2002 | WO2001070767A3 Therapeutic anti-melanoma compounds |
| 01/24/2002 | WO2001064750A3 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 01/24/2002 | WO2001060838A3 Aids ancestral viruses and vaccines |
| 01/24/2002 | WO2001059115A3 83p5g4: a tissue specific protein highly expressed in prostate cancer |
| 01/24/2002 | WO2001055324A3 Nucleic acids, proteins, and antibodies |
| 01/24/2002 | WO2001053324A3 Novel haptotactic peptides |
| 01/24/2002 | WO2001051515A3 Genes differentially expressed in breast cancer |
| 01/24/2002 | WO2001046258A3 Transporters and ion channels |
| 01/24/2002 | WO2001042465A3 Chordin-like molecules and uses thereof |
| 01/24/2002 | WO2001036977A8 Identification of disease markers involving mass-based-separation |
| 01/24/2002 | WO2001036470A3 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 01/24/2002 | WO2001036005A3 Targeted delivery of therapeutic and diagnostic moieties |
| 01/24/2002 | WO2001034768A3 15 human secreted proteins |
| 01/24/2002 | WO2001032910A3 27 human secreted proteins |
| 01/24/2002 | WO2001025436A3 Endozepine-like polypeptides and polynucleotides encoding same |
| 01/24/2002 | WO2001023409A8 38 human secreted proteins |
| 01/24/2002 | WO2001019860A3 Proteins associated with cell differentiation |
| 01/24/2002 | WO2001016290A3 Dna encoding the human serine protease eos |
| 01/24/2002 | WO2001012819A3 Protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 01/24/2002 | WO2001000679A3 Methods for inducing t cell non-responsiveness to a tissue or organ graft |
| 01/24/2002 | WO2000073453A9 T-bet compositions and methods of use thereof |
| 01/24/2002 | WO2000073338A9 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 01/24/2002 | WO2000071574A3 Antigenic neisserial peptides |
| 01/24/2002 | WO2000053168A3 Synergy between low molecular weight heparin and platelet aggregation inhibitors, for preventing and treating thromboembolic disorders |
| 01/24/2002 | US20020010325 Complexing; purified polypeptide |
| 01/24/2002 | US20020010324 Genetic engineering; polypeptides |
| 01/24/2002 | US20020010321 Truncated forms of NY-ESO-1 protein |
| 01/24/2002 | US20020010320 Chemeric and humanized antibodies to angiogenin |
| 01/24/2002 | US20020010319 Separation of polypeptide monomers |
| 01/24/2002 | US20020010318 Enzyme inhibitor; for use in treatment of lung defects, asthma, bronchitis, emphysema and respiratory system disorders |
| 01/24/2002 | US20020010180 Treatment of rheumatoid arthritis, Crohn's disease, acute and chronic immune diseases associated with transplantation |
| 01/24/2002 | US20020010126 Administering an agent which antagonizes the effects of a colony stimulating factor on these monocyte/macrophage cells to lower levels or reduce their activity; treating inflammation |
| 01/24/2002 | US20020009776 Fibroblast growth factor receptor-like molecules and uses thereof |
| 01/24/2002 | US20020009761 Superficial zone protein-binding molecules and uses thereof |
| 01/24/2002 | US20020009758 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/24/2002 | US20020009755 Metastatic classification of tumors; obtain tumor biopsy, monitor expression of preferential receptor isoform, amplified quantities of preferential receptor isoform indicates potential for matastasis |
| 01/24/2002 | US20020009753 Anticoagulant test |